Recent News

• 11.17.2025 - Adaptimmune Announces Changes to Board and Executive Leadership Team
• 10.20.2025 - Adaptimmune Announces Delisting from Nasdaq

Recent Filings

• 11.14.2025 - EFFECT Notice of Effectiveness
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.13.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 11.13.2025 - 15-12G Securities registration termination [Section 12(g)]
• 10.28.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 10.28.2025 - POS AM Post-Effective amendments for registration statement
• 10.28.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 10.28.2025 - 25 Notification of the removal from listing and registration of matured, redeemed or retired securities
• 10.28.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 10.20.2025 - 8-K Current report